Matches in SemOpenAlex for { <https://semopenalex.org/work/W164157635> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W164157635 abstract "T he role of money in biomedical research is a frequent point of controversy. Concern focuses on the extent to which money offered to prospective subjects may unduly influence them to participate in a study and on investigator/institutional financial conflicts of interest.' Additional concerns that have received considerably less attention involve the permissibility of charging subjects for participating in research and the extent to which investigators should disclose these costs to prospective subjects. Costs associated with research participation generally fall into two categories: health system related expenses paid directly to entities that provide health services, such as hospitals, labs, clinics, and pharmacies; and non-health system related expenses such as fees to public transit or taxi companies, gas stations, and parking garages. Some health system related expenses are expected costs (e.g., tests or services that will not or will likely not be covered by third party payers) whereas others are not (e.g., injury-related costs). This paper focuses on the former, which are both knowable and quantifiable in advance. Although most research studies do not impose anticipated health system related costs on subjects, some do, and the Food and Drug Administration (FDA) explicitly permits the practice in some cases.3 Federal regulations governing human subjects research stipulate that, when appropriate, prospective subjects should be informed of any additional costs to the subject that may result from participation in the research.4 Yet, the regulations do not state whether the costs must be itemized or what level of detail must be provided. Institutional Review Boards (IRBs) vary in how they interpret this regulatory requirement.s Some have explicit policies requiring detailed disclosure of costs, but others do not.6 Because the Office for Human Research Protections (OHRP) and the FDA have offered little guidance on how they expect the regulations to be interpreted, there is both an opportunity and an obligation to consider the issues from an ethical perspective.7" @default.
- W164157635 created "2016-06-24" @default.
- W164157635 creator A5054596300 @default.
- W164157635 date "2004-11-01" @default.
- W164157635 modified "2023-09-23" @default.
- W164157635 title "Costs to Subjects for Research Participation and the Informed Consent Process: Regulatory and Ethical Considerations" @default.
- W164157635 cites W1497591368 @default.
- W164157635 cites W1564853100 @default.
- W164157635 cites W1969704932 @default.
- W164157635 cites W1973942757 @default.
- W164157635 cites W1983235508 @default.
- W164157635 cites W2002076933 @default.
- W164157635 cites W2072399511 @default.
- W164157635 cites W2080301318 @default.
- W164157635 cites W2100860747 @default.
- W164157635 cites W2130071626 @default.
- W164157635 cites W2133650606 @default.
- W164157635 cites W2139623473 @default.
- W164157635 cites W2168896494 @default.
- W164157635 cites W2169526955 @default.
- W164157635 cites W2214504830 @default.
- W164157635 cites W2319927781 @default.
- W164157635 cites W3123664136 @default.
- W164157635 cites W342569008 @default.
- W164157635 cites W2036441870 @default.
- W164157635 doi "https://doi.org/10.2307/3564097" @default.
- W164157635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15658017" @default.
- W164157635 hasPublicationYear "2004" @default.
- W164157635 type Work @default.
- W164157635 sameAs 164157635 @default.
- W164157635 citedByCount "3" @default.
- W164157635 countsByYear W1641576352012 @default.
- W164157635 crossrefType "journal-article" @default.
- W164157635 hasAuthorship W164157635A5054596300 @default.
- W164157635 hasConcept C100001284 @default.
- W164157635 hasConcept C104863432 @default.
- W164157635 hasConcept C142724271 @default.
- W164157635 hasConcept C144133560 @default.
- W164157635 hasConcept C162118730 @default.
- W164157635 hasConcept C162324750 @default.
- W164157635 hasConcept C162853370 @default.
- W164157635 hasConcept C17744445 @default.
- W164157635 hasConcept C204787440 @default.
- W164157635 hasConcept C39549134 @default.
- W164157635 hasConcept C512399662 @default.
- W164157635 hasConcept C68122502 @default.
- W164157635 hasConcept C71924100 @default.
- W164157635 hasConceptScore W164157635C100001284 @default.
- W164157635 hasConceptScore W164157635C104863432 @default.
- W164157635 hasConceptScore W164157635C142724271 @default.
- W164157635 hasConceptScore W164157635C144133560 @default.
- W164157635 hasConceptScore W164157635C162118730 @default.
- W164157635 hasConceptScore W164157635C162324750 @default.
- W164157635 hasConceptScore W164157635C162853370 @default.
- W164157635 hasConceptScore W164157635C17744445 @default.
- W164157635 hasConceptScore W164157635C204787440 @default.
- W164157635 hasConceptScore W164157635C39549134 @default.
- W164157635 hasConceptScore W164157635C512399662 @default.
- W164157635 hasConceptScore W164157635C68122502 @default.
- W164157635 hasConceptScore W164157635C71924100 @default.
- W164157635 hasLocation W1641576351 @default.
- W164157635 hasLocation W1641576352 @default.
- W164157635 hasOpenAccess W164157635 @default.
- W164157635 hasPrimaryLocation W1641576351 @default.
- W164157635 hasRelatedWork W1495392251 @default.
- W164157635 hasRelatedWork W1577304412 @default.
- W164157635 hasRelatedWork W1594788928 @default.
- W164157635 hasRelatedWork W2020496528 @default.
- W164157635 hasRelatedWork W206325704 @default.
- W164157635 hasRelatedWork W2075078836 @default.
- W164157635 hasRelatedWork W2397770754 @default.
- W164157635 hasRelatedWork W2743040980 @default.
- W164157635 hasRelatedWork W2751680336 @default.
- W164157635 hasRelatedWork W66695244 @default.
- W164157635 isParatext "false" @default.
- W164157635 isRetracted "false" @default.
- W164157635 magId "164157635" @default.
- W164157635 workType "article" @default.